Showing 181-190 of 210 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20790/What About Diet? The Complex Relationship between Food and Atopic Dermatitis
https://practicaldermatology.com/columns/clinical-focus-1/what-about-diet-the-complex-relationship-between-food-and-atopic-dermatitis/23175/Exploring the clinical implications of our current understanding of diet and eczema.Hyperpigmentation in Darker Skin Types: A Review of Current Treatments
https://practicaldermatology.com/programs/practical-dermatology/hyperpigmentation-in-darker-skin-types-a-review-of-current-treatments/24217/Pigmentary disorders are a leading concern for patients and consumers worldwide.Resolution of Primary Erythromelalgia Following Ibuprofen; Fire Power
https://practicaldermatology.com/youngmd-connect/resident-resource-center/resolution-of-primary-erythromelalgia-following-ibuprofen-fire-power/20619/Psychodermatology: A Review
https://practicaldermatology.com/topics/practice-management/psychodermatology-a-review/21180/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-38/23774/Melasma Treatments: A Review of Laser Therapies and the Integration of Reflectance Confocal Microscopy
https://practicaldermatology.com/topics/general-topics/melasma-treatments-a-review-of-laser-therapies-and-the-integration-of-reflectance-confocal-microscopy/21363/Reflectance confocal microscopy may play a role in melasma stratification and treatment assessment.Which Probiotic for Which Disease? Part 1
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-1/23550/Enhanced interest in probiotics means clinicians need to pick the best strain for common dermatologic conditions.Pruritus In PN and AD: Challenge How You Manage Itch
https://practicaldermatology.com/programs/cme/pruritus-in-pn-and-ad-challenge-how-you-manage-itch/36304/Use validated assessment tools to prioritize and measure itch in prurigo nodularis and atopic dermatitis in an interactive CME escape room.How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended surviv